Summary of Significant Accounting Policies (Details Narrative) (USD $)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2013
Sales Returns and Allowances
Allowance for customer returns			$ 85,000		$ 70,000
Receivables
Note receivable	89,071		89,071
Note receivable, additional disclosure					The predecessor company disposed of a dormant product line of vitamins in December 2010. As part of the consideration in this divestiture, the Company received from the purchaser of this product line an unsecured note in the amount of $170,000. The original note was due to be repaid on or before March 2014, where interest accrued principally at an annual rate of 5%, based upon the initial $170,000 principal and was payable monthly. As of March 31, 2013, the note was novated and a new promissory note was issued to reflect a modification in the payment terms, which includes no interest.
Note receivable, maturity date			May 01, 2017
Revenue Recognition
Revenue recognition, returns, allowances and discounts	849,356	293,498	1,360,091	1,008,528
Deferred revenue	214,977		214,977		292,215
Leases
Leases, rent expense	20,716	20,716	41,432	41,432
Leases, description			The Company leases its headquarters facility, comprising approximately 10,044 square feet, in Golden, Colorado. The lease term expires January 31, 2017 and requires equal monthly payments over the remaining term.
Leases, future payments	214,063		214,063
Marketing
Marketing, deferred advertising costs	0		0		7,651
Marketing, expense	314,696	178,720	942,119	324,930
Research and Development Expense
Research and development costs	$ 4,481	$ 28,701	$ 10,905	$ 88,514